Advertisement
UK markets close in 43 minutes
  • FTSE 100

    8,068.15
    +27.77 (+0.35%)
     
  • FTSE 250

    19,604.26
    -115.11 (-0.58%)
     
  • AIM

    752.91
    -1.78 (-0.24%)
     
  • GBP/EUR

    1.1665
    +0.0020 (+0.17%)
     
  • GBP/USD

    1.2502
    +0.0039 (+0.32%)
     
  • Bitcoin GBP

    50,804.32
    -1,104.58 (-2.13%)
     
  • CMC Crypto 200

    1,377.67
    -4.91 (-0.35%)
     
  • S&P 500

    5,003.48
    -68.15 (-1.34%)
     
  • DOW

    37,777.33
    -683.59 (-1.78%)
     
  • CRUDE OIL

    82.28
    -0.53 (-0.64%)
     
  • GOLD FUTURES

    2,352.70
    +14.30 (+0.61%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,890.31
    -198.39 (-1.10%)
     
  • CAC 40

    8,005.64
    -86.22 (-1.07%)
     

Abbott Slides On Revenue Lag, But Outlook Prods Drug Stocks

Abbott Slides On Revenue Lag, But Outlook Prods Drug Stocks

Medical giant Abbott Laboratories issued upbeat 2019 revenue guidance Wednesday, but shares dipped on lagging fourth-quarter revenue and a continued slowdown for its neuromodulation unit.